| 40375-8 |
Lutropin^20M post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --20 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
40375-8 |
|
|
|
|
Observation |
|
|
|
0 |
LH 20M p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
20M p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
| 40376-6 |
Lutropin^2H post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --2 hours post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
40376-6 |
|
|
|
|
Observation |
|
|
|
0 |
LH 2h p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
120 min; 120 minutes; 120min; 2 hours; 2h p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
| 40377-4 |
Lutropin^30M post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --30 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
40377-4 |
|
|
|
|
Observation |
|
|
|
0 |
LH 30M p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
30M p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
| 40378-2 |
Lutropin^pre dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lutropin [Units/volume] in Serum or Plasma --pre dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/mL;IU/L |
|
|
|
|
|
|
CHAL |
|
40378-2 |
|
|
|
|
Observation |
|
|
|
0 |
LH pre Triple Bolus SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; ICSH; Interstitial cell-stimulating hormone; Interstitual cell stimulating hormone; Leutinizing hormone; LH; Luteinizing hormone; Lutenin; Lutenizing hormone; Ovulation test; Pl; Plasma; Plsm; Point in time; pre Triple Bolus; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tri; Trip |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/mL |
|
|
|
0 |
| 40379-0 |
Maprotiline |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Maprotiline [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40379-0 |
|
|
|
|
Both |
|
|
|
0 |
Maprotiline Gast Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ludiomil; Novartis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4038-6 |
Stanozolol |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Stanozolol [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ng/24 H |
|
|
|
|
|
|
DRUG/TOX |
|
4038-6 |
|
|
|
|
Both |
|
|
|
0 |
Stanozolol 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Androstanazole; DRUG/TOXICOLOGY; Drugs; Mass rate; Methylstanazole; mRate; QNT; Quan; Quant; Quantitative; Stromba; Strombaject; UA; UR; Urn; Winstrol |
2.42 |
1 |
|
|
|
|
|
|
|
ng/(24.h) |
|
|
|
0 |
| 40380-8 |
Meprobamate |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Meprobamate [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40380-8 |
|
|
|
|
Both |
|
|
|
0 |
Meprobamate Gast Ql |
|
|
|
N |
|
Addiction; Carisoprodol metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Equanil; GAST; Gastric contents; Gastric fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40381-6 |
Methamphetamine |
PrThr |
XXX |
Pt |
Ord |
|
|
ACTIVE |
Methamphetamine [Presence] in Specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40381-6 |
|
|
|
|
Both |
|
|
|
0 |
Methamphet Spec Ql |
|
|
|
N |
|
Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methamphet; Misc; Miscellaneous; Ordinal; Other; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40382-4 |
Methaqualone |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Methaqualone [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40382-4 |
|
|
|
|
Both |
|
|
|
0 |
Methaqualone Gast Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Methaqualon; Ordinal; Point in time; PotentialForAbuse; PR; QL; Quaalude; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40383-2 |
Methyprylon |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Methyprylon [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40383-2 |
|
|
|
|
Both |
|
|
|
0 |
Methyprylon Gast Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Methprylon; Noludar; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40384-0 |
Morphine |
PrThr |
Hair |
Pt |
Ord |
|
|
ACTIVE |
Morphine [Presence] in Hair |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40384-0 |
|
|
|
|
Both |
|
|
|
0 |
Morphine Hair Ql |
|
|
|
N |
|
Addiction; c260; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Morphine sulfate; MS; MSO4; OMPH; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40385-7 |
Nicotine |
PrThr |
Meconium |
Pt |
Ord |
|
|
ACTIVE |
Nicotine [Presence] in Meconium |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40385-7 |
|
|
|
|
Both |
|
|
|
0 |
Nicotine Mec Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Illicit; Mec; Nicoderm; Nictoine; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40386-5 |
Nicotine |
PrThr |
Hair |
Pt |
Ord |
|
|
ACTIVE |
Nicotine [Presence] in Hair |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40386-5 |
|
|
|
|
Both |
|
|
|
0 |
Nicotine Hair Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Habitrol; Har; Illicit; Nicoderm; Nictoine; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40387-3 |
Nicotine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Nicotine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40387-3 |
|
|
|
|
Both |
|
|
|
0 |
Nicotine Gast Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Habitrol; Illicit; Nicoderm; Nictoine; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40388-1 |
Nitrogen |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Nitrogen [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mmol/24 H |
|
|
|
|
|
|
CHEM |
|
40388-1 |
|
|
|
|
Both |
|
|
|
0 |
N2 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; N; N2; Nit; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
| 40389-9 |
Nortriptyline |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Nortriptyline [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40389-9 |
|
|
|
|
Both |
|
|
|
0 |
Nortrip Gast Ql |
|
|
|
N |
|
Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 4039-4 |
Streptomycin |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Streptomycin [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
4039-4 |
|
|
|
|
Both |
|
|
|
0 |
Streptomycin SerPl-mCnc |
|
|
|
Y |
|
Aminoglycosides; c232; C295; Cidam est; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Novostrep; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Solustrep; SR; Streptocol; Strepto-fatol; Streptomyc |
2.73 |
1 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 40390-7 |
OLANZapine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
OLANZapine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40390-7 |
|
|
|
|
Both |
|
|
|
0 |
OLANZapine Ur Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Lanzek; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn; Zypadhera; Zyprexa |
2.73 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40391-5 |
Para aminobenzoate.free |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Para aminobenzoate free [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mg/L |
|
|
|
|
|
|
DRUG/TOX |
|
40391-5 |
|
|
|
|
Both |
|
|
|
0 |
pABA Free SerPl-mCnc |
|
|
|
N |
|
Aminobenzoic acid; c701; DRUG/TOXICOLOGY; Drugs; FR; Level; Mass concentration; Non-protein bound; p Aminobenzoate; PAB; PABA; pABA Free; Pabanol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.15 |
|
|
|
|
|
|
|
mg/L |
|
|
|
0 |
| 40392-3 |
Pentacarboxylate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Pentacarboxylate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
40392-3 |
|
|
|
|
Both |
|
|
|
0 |
Pentacarboxylate 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; QNT; Quan; Quant; Quantitative; sRate; Substance rate; UA; UR; Urn |
2.7 |
2.15 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
| 40393-1 |
Pentazocine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Pentazocine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40393-1 |
|
|
|
|
Both |
|
|
|
0 |
Pentazocine Gast Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Talwin |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40394-9 |
Phencyclidine |
PrThr |
Hair |
Pt |
Ord |
|
|
ACTIVE |
Phencyclidine [Presence] in Hair |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40394-9 |
|
|
|
|
Both |
|
|
|
0 |
PCP Hair Ql |
|
|
|
N |
|
Addiction; Angel dust; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Sernylan |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40395-6 |
Phentermine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Phentermine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
40395-6 |
|
|
|
|
Both |
|
|
|
0 |
Phentermine Gast Ql |
|
|
|
N |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GAST; Gastric contents; Gastric fluid; Illicit; Ionamin; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen |
2.56 |
2.15 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 40396-4 |
Porphyrins |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Porphyrins [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
40396-4 |
|
|
|
|
Both |
|
|
|
0 |
Porphyrins 24h Ur-sRate |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Hematology; Heme; Porph; Porphyrin; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
2.15 |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 40397-2 |
Thyrotropin^15M post dose triple bolus |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post dose triple bolus |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
40397-2 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 15M p Triple Bolus SerPl-aCnc |
|
|
|
N |
|
15M p Triple Bolus; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; Tri; Trip; TSH |
2.7 |
2.15 |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
